-

Coty Launches Scientific Advisory Board on Skincare Innovation

MONACO--(BUSINESS WIRE)--Coty Inc. (NYSE: COTY)(Paris: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, skin and body care, proudly announces the launch of its first Scientific Advisory Board, following the inaugural meeting on September 24, 2024.

The Advisory Board brings together globally renowned scientific experts from diverse technical disciplines, selected for their unique expertise and contribution to cutting-edge research. The Board will convene twice a year to inform and inspire breakthrough innovations within Coty’s R&D specialists, and therefore strengthen Coty’s efforts to shape the future of skincare.

The first meeting, held at Coty’s Skincare Research & Innovation Center of Excellence in Monaco, brought together these leading scientists to discuss the current themes in skin health and skin repair. The experts provided valuable insights and feedback that will continue to shape Coty’s R&D initiatives and product innovation strategies across all its skincare brands.

Sue Nabi, CEO of Coty, said: “This year marks our 120th anniversary as pioneers in the beauty industry, and I’m honored that such acclaimed scientific minds have agreed to come together to help define the future of Coty skincare as part of our Scientific Advisory Board. Each member has been carefully selected because they are at the forefront of their respective disciplines. Their ongoing insights will play a pivotal role as we continue to collaborate and drive skincare innovation forward for the benefit of all our consumers.”

The Scientific Advisory Board will serve as a forum for the exchange of cutting-edge ideas, innovative thinking, and rigorous challenge. In line with Coty’s commitment to co-creation, the board will align the latest science with emerging trends and consumer needs, which will enhance Coty’s leading position in skin science.

Appropriately, the inaugural meeting of the Scientific Advisory Board took place at Coty’s Center of Excellence in Monaco, where one of the company’s flagship skincare brands was founded 70 years ago.

Members of Coty’s Scientific Advisory Board

Dr. Miriam Merad, MD, PhD – Director of Precision Immunology Institute - New York
Dr. Emma Guttman, MD, PhD – Professor of Dermatology & Immunology - New York
Dr. Patrick Bui, MD – Head of Plastic Surgery Department American Hospital - Paris
Pr. Selim Aractingi, MD, PhD – Team Leader, Cutaneous Biology Labs, Cochin Institute - Paris
Pr. Wei Liu, MD, PhD – Dermatologist - Beijing
Pr. Deng Xingwang – Professor of Life Science - Beijing
Dr. Jaci Santana, MD – Dermatologist - Recife

About Coty Inc.

Founded in Paris in 1904, Coty is one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care. We serve consumers around the world, selling prestige and mass market products in more than 125 countries and territories. Coty and our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to protecting the planet. Learn more at coty.com or on LinkedIn and Instagram.

Contacts

Coty Inc.

NYSE:COTY

Release Versions

Contacts

Social Media Profiles
More News From Coty Inc.

Coty Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2026

NEW YORK--(BUSINESS WIRE)--Regulatory News: Coty Inc. (NYSE: COTY; PARIS: COTY) today announced that on August 20, 2026, the Company filed its annual report on Form 10-K for the fiscal year ended June 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”). The annual report is available on the SEC’s website at: https://www.sec.gov/ix?doc=/Archives/edgar/data/1024305/000102430526000048/coty-20260630.htm. About Coty Inc. Founded in Paris in 1904, Coty is one of the world’s largest...

Coty Announces Fourth Quarter Fiscal Year 2026 Results

NEW YORK--(BUSINESS WIRE)--Regulatory News: Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") today announced its results for the fourth quarter of fiscal year 2026, ended June 30, 2026. Coty delivered Q4 and FY26 sales, profit, and cash flow ahead of expectations, supported by cost control and the convergence of sales and sell-out. "We closed FY26 on a stronger note, delivering sales and profit ahead of our targets, growing free cash flow even in the face of business headwinds, al...

Coty Appoints Soraya Benchikh Chief Financial Officer

NEW YORK--(BUSINESS WIRE)--Regulatory News: Coty Inc. (NYSE: COTY; PARIS: COTY) ("Coty" or "the Company") today announced the appointment of Soraya Benchikh as Chief Financial Officer (CFO), effective September 1, 2026. Benchikh succeeds Laurent Mercier. The appointment follows the new operating structure Coty put in place on July 2, which brought commercial decision-making closer to the markets Coty serves and combined research and development, and supply chain, into a single function. Markus...
Back to Newsroom